Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Questcor Pharma: Acthar Approval Seems Likely
Seeking Alpha
Sunday, August 22, 2010 - 11:59am
tags:
Questcor Pharmaceuticals, Acthar, infantile spasms
SkyePharma regains United States marketing rights to Flutiform
PipeLine Review
Saturday, August 21, 2010 - 1:58pm
tags:
SkyePharma, Flutiform, asthma
TIME: Glaxo Knew of Avandia Heart Attack Risk
Lawyers and Settlements
Saturday, August 21, 2010 - 1:56pm
tags:
GSK, Avandia, legal
Aurobindo Pharma gets US FDA's nod for Ampicillin injection
The Economic Times, India
Saturday, August 21, 2010 - 1:54pm
tags:
Aurobindo, Ampicillin injection
US FDA committee recommends expanded approval for Eli Lilly's Cymbalta to a broader pain population
Pharmabiz
Saturday, August 21, 2010 - 1:51pm
tags:
Eli Lilly, Cymbalta, pain management
Regenerative medicine gets on a profitable roll
Mass High Tech
Saturday, August 21, 2010 - 1:48pm
tags:
regenerative medicine, Cell Therapy Group, Apligraf
J&J: Bond or Stock
Yahoo/Morningstar
Saturday, August 21, 2010 - 1:44pm
tags:
JNJ
EntreMed gets notice of Nasdaq violation
Yahoo/AP
Saturday, August 21, 2010 - 1:39pm
tags:
EntreMed, investors
Panel Slams ‘Date Rape’ Drug For Fibromyalgia
Forbes
Saturday, August 21, 2010 - 1:37pm
tags:
Jazz Pharmaceuticals, Rekinla, fibromyalgia
Celgene's Revlimid Marches on
Yahoo/Zacks
Saturday, August 21, 2010 - 1:35pm
tags:
Celgene, Revlimid, Multiple Myeloma
Repros stock gets boost on analyst upgrade
bizjournals.com
Saturday, August 21, 2010 - 1:31pm
tags:
Repros Therapeutics, Androxal, testosterone
Dividends Aren't Enough: Biotech
Motley Fool
Saturday, August 21, 2010 - 10:48am
tags:
Gilead Sciences, Amgen, Genzyme, Dendreon, Biogen Idec
Which biotechs are the least efficient?
Fierce Biotech
Friday, August 20, 2010 - 12:53pm
tags:
MannKind, Orexigen, Aastrom, Hemispherx, Cell Therapeutics
Drugmaker Elan Tempts the SEC to Investigate Its Tangled, Undisclosed Deals
BNET Pharma
Friday, August 20, 2010 - 12:51pm
tags:
Elan, SEC, epilepsy, lorazepam, Amarin
Dividends Aren't Enough: Biotech
Motley Fool
Friday, August 20, 2010 - 12:48pm
tags:
biotech, Gilead Sciences, Amgen, Genzyme, Biogen Idec, Dendreon
Analyst:Cymbalta sales won't offset Lilly's losses
Yahoo/AP
Friday, August 20, 2010 - 12:47pm
tags:
Cymbalta, FDA, Eli Lilly, chronic pain
CEO Is Latest Hospira Exec Hitting The Road
Forbes
Friday, August 20, 2010 - 12:46pm
tags:
Pharma CEOs, Christopher Begley, Hospira
Eli Lilly Setback Could Pave Way For New Alzheimer’s Approach
Forbes
Friday, August 20, 2010 - 12:45pm
tags:
Eli Lilly, Alzheimer's disease, Pfizer, Elan, Bristol-Myers Squibb
Impax Labs challenges Vytorin patents
Yahoo/AP
Friday, August 20, 2010 - 10:57am
tags:
Vytorin, Impax Labs, patents, Merck
Generic Risk For Gilead's Hepsera
Yahoo/Zacks.com
Friday, August 20, 2010 - 10:56am
tags:
Gilead Sciences, Hepsera, generics, Bristol-Myers Squibb, Merck, hepatitis B

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.